155 related articles for article (PubMed ID: 21946330)
1. Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers.
Lima SC; Hernández-Vargas H; Simão T; Durand G; Kruel CD; Le Calvez-Kelm F; Ribeiro Pinto LF; Herceg Z
Epigenetics; 2011 Oct; 6(10):1217-27. PubMed ID: 21946330
[TBL] [Abstract][Full Text] [Related]
2. Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.
Li X; Zhou F; Jiang C; Wang Y; Lu Y; Yang F; Wang N; Yang H; Zheng Y; Zhang J
PLoS One; 2014; 9(7):e103162. PubMed ID: 25050929
[TBL] [Abstract][Full Text] [Related]
3.
Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
[TBL] [Abstract][Full Text] [Related]
5. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
6. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.
Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X
Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536
[TBL] [Abstract][Full Text] [Related]
8. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.
Ma K; Cao B; Guo M
Clin Epigenetics; 2016; 8():43. PubMed ID: 27110300
[TBL] [Abstract][Full Text] [Related]
9. Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression.
Cheng CP; Kuo IY; Alakus H; Frazer KA; Harismendy O; Wang YC; Tseng VS
Bioinformatics; 2014 Nov; 30(21):3054-61. PubMed ID: 25015989
[TBL] [Abstract][Full Text] [Related]
10. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
[TBL] [Abstract][Full Text] [Related]
11. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.
Roth MJ; Abnet CC; Hu N; Wang QH; Wei WQ; Green L; D'Alelio M; Qiao YL; Dawsey SM; Taylor PR; Woodson K
Oncol Rep; 2006 Jun; 15(6):1591-7. PubMed ID: 16685400
[TBL] [Abstract][Full Text] [Related]
12. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.
Zhao BJ; Sun DG; Zhang M; Tan SN; Ma X
Dis Esophagus; 2009; 22(1):55-61. PubMed ID: 18564167
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma.
Chen C; Peng H; Huang X; Zhao M; Li Z; Yin N; Wang X; Yu F; Yin B; Yuan Y; Lu Q
Oncotarget; 2016 Jan; 7(4):4507-21. PubMed ID: 26683359
[TBL] [Abstract][Full Text] [Related]
14. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
Sheyhidin I; Hasim A; Zheng F; Ma H
Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma.
Li JS; Ying JM; Wang XW; Wang ZH; Tao Q; Li LL
Chin J Cancer; 2013 Jan; 32(1):3-11. PubMed ID: 22572016
[TBL] [Abstract][Full Text] [Related]
17. RASSF1A gene promoter methylation in esophageal cancer specimens.
Yamaguchi S; Kato H; Miyazaki T; Sohda M; Kimura H; Ide M; Asao T; Kuwano H
Dis Esophagus; 2005; 18(4):253-6. PubMed ID: 16128782
[TBL] [Abstract][Full Text] [Related]
18. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
[TBL] [Abstract][Full Text] [Related]
19. Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma.
Wong VC; Chan PL; Bernabeu C; Law S; Wang LD; Li JL; Tsao SW; Srivastava G; Lung ML
Int J Cancer; 2008 Dec; 123(12):2816-23. PubMed ID: 18798555
[TBL] [Abstract][Full Text] [Related]
20. Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma.
Abbaszadegan MR; Raziee HR; Ghafarzadegan K; Shakeri MT; Afsharnezhad S; Ghavamnasiry MR
Int J Gastrointest Cancer; 2005; 36(1):47-54. PubMed ID: 16227635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
